Residency in Spain is required. This role is currently fully remote. #LI-Remote At JFrog, we are reinventing DevOps to help the world’s greatest companies innovate - and we want you along for the ride. This is
The Vall d´Hebron Institute of Oncology (VHIO) Seeks a “Cancer Genomics Bioinformatician” Reference: 2026-056-01 Application deadline: Until the position is filled Number of vacancies: 1 Job description: The newly established Cancer Genome Dynamics Group led by
Let’s be unstoppable together! Descubra si esta oportunidad es adecuada para usted leyendo toda la información que sigue a continuación. Circana is a leading provider of technology, AI, and data solutions for consumer packaged goods companies,
I&C Engineer (Installation & Commissioning Engineer) Location: Madrid, Spain Dé el siguiente paso en su carrera profesional ahora: desplácese hacia abajo para leer la descripción completa del puesto y envíe su solicitud. About the Role We
IMDEA Materials Institute is a public research organization founded in 2007 by Madrid’s regional government to carry out research of excellence in Material Science and Engineering by attracting talent from all over the world to work
Experteer Overview Asegúrese de enviar su solicitud rápidamente para maximizar sus posibilidades de ser considerado para una entrevista. Lea la descripción completa del puesto a continuación. In this role you will design and build batch and
Flomics is a fast-growing biotech company founded in 2018 in Barcelona. We are developing a revolutionary liquid biopsy test for the early detection of cancer, based on the analysis of cell-free RNA in blood. By combining cutting-edge
Flomics is a fast-growing biotech company founded in 2018 in Barcelona. We are developing a revolutionary liquid biopsy test for the early detection of cancer, based on the analysis of cell-free RNA in blood. By combining cutting-edge
Flomics is a fast-growing biotech company founded in 2018 in Barcelona. We are developing a revolutionary liquid biopsy test for the early detection of cancer, based on the analysis of cell-free RNA in blood. By combining cutting-edge